Influence of decompensated heart failure on cardiac acoustic biomarkers: impact on early readmissions.
Cardiac acoustic biomarkers
HFrEF
Heart failure
Hospitalization
Wearable cardioverter-defibrillator
Journal
ESC heart failure
ISSN: 2055-5822
Titre abrégé: ESC Heart Fail
Pays: England
ID NLM: 101669191
Informations de publication
Date de publication:
Dec 2020
Dec 2020
Historique:
revised:
10
09
2020
received:
14
06
2020
accepted:
16
09
2020
pubmed:
17
10
2020
medline:
17
10
2020
entrez:
16
10
2020
Statut:
ppublish
Résumé
Preventing hospitalization by detecting early evidence of heart failure (HF) decompensation in an outpatient setting can improve patient's quality of life and reduce costs of care. The purpose of this study was to assess the value of cardiac acoustic biomarkers (CABs), a combination of cardiohaemic vibrations synchronized with ECG signals, and heart rate (HR) for detecting HF decompensation during first 3 months after hospital discharge for HF. Patients with an ejection fraction ≤35% (HFrEF) and hospitalized for decompensated HF were enrolled in a prospective observational study. All subjects wore a wearable cardioverter-defibrillator (ZOLL LifeVest This prospective international registry showed that an algorithm incorporating CABs and HR data detected HF events 30 days in advance of the event in patients with HFrEF during first 3 months after hospital discharge. Therefore, integrating CAB technology into clinical practice may prevent HF rehospitalizations.
Identifiants
pubmed: 33063460
doi: 10.1002/ehf2.13045
pmc: PMC7754974
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
4198-4205Subventions
Organisme : ZOLL Medical Corporation
Informations de copyright
© 2020 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of the European Society of Cardiology.
Références
Ambrosy AP, Pang PS, Khan S, Konstam MA, Fonarow GC, Traver B, Maggioni AP, Cook T, Swedberg K, Burnett JC, Grinfeld L, Udelson JE, Zannad F, Gheorghiade M. On behalf of the EVEREST trial investigators Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial. Eur Heart J 2013; 34: 835-843.
Ross JS, Chen J, Lin Z, Bueno H́, Curtis JP, Keenan PS, Normand SLT, Schreiner G, Spertus JA, Vidán MT, Wang Y, Wang Y, Krumholz HM. Recent national trends in readmission rates after heart failure hospitalization. Circ Heart Fail 2010; 3: 97-103.
Saito M, Negishi K, Marwick TH. Meta-analysis of risks for short-term readmission in patients with heart failure. J Cardiol 2016; 117: 626-632.
Zile MR, Bennett TD, St. John Sutton M, Cho YK, Adamson PB, Aaron MF, Aranda JM Jr, Abraham WT, Smart FW, Stevenson LW, Kueffer FJ, Bourge RC. Transition from chronic compensated to acute decompensated heart failure: pathophysiological insights obtained from continuous monitoring of intracardiac pressures. Circulation 2008; 118: 1433-1441.
Ritzema J, Troughton R, Melton I, Crozier I, Doughty R, Krum H, Walton A, Adamson P, Kar S, Shah PK, Richards M, Eigler NL, Whiting JS, Haas GJ, Heywood JT, Frampton CM, Abraham WT. Physician-directed patient self-management of left atrial pressure in advanced chronic heart failure. Circulation 2010; 121: 1086-1095.
Bhimaraj A. Remote monitoring of heart failure patients. Methodist Debakey Cardiovasc J 2013; 9: 26-31.
Abraham WT, Stough WG, Pina IL, Linde C, Borer JS, De Ferrari GM, Mehran R, Stein KM, Vincent A, Yadav JS, Anker SD. Trials of implantable monitoring devices in heart failure: which design is optimal? Nat Rev Cardiol 2014; 11: 576-585.
Sung S-H, Yu W-C, Cheng H-M, Chang Y-P, Chen C-H. Use of acoustic cardiography to guide outpatient therapy of patients with acute heart failure syndrome. J Am Coll Cardiol 2014; 63: A541.
Klein HU, Meltendorf U, Reek S, Smid JA, Kuss S, Cygankiewicz I, Jons C, Szymkiewicz S, Buhtz F, Wollbrueck A, Zareba W. Bridging a temporary high risk of sudden arrhythmic death. Experience with the wearable cardioverter defibrillator (WCD). Pacing Clin Electrophysiol 2010; 33: 353-367.
Chun S, Tu JV, Wijeysundera HC, Austin PC, Wang X, Levy D, Lee DS. Lifetime analysis of hospitalizations and survival of patients newly admitted with heart failure. Circ Heart Fail 2012; 5: 414-421.
Desai AS, Stevenson LW. Rehospitalization for heart failure: predict or prevent? Circulation 2012; 126: 501-506.
Chang CC, Sung SH, Yu WC, Cheng HM, Chen CH. Night-time electromechanical activation time, pulsatile hemodynamics, and discharge outcomes in patients with acute heart failure. ESC Hear Fail 2015; 2: 184-193.
Collins SP, Lindsell CJ, Peacock WF, Hedger VD, Storrow AB. The effect of treatment on the presence of abnormal heart sounds in emergency department patients with heart failure. Am J Emerg Med 2006; 24: 25-32.
Sung S, Huang C, Cheng H, Huang WM, Yu WC, Chen CH. Effect of acoustic cardiography-guided management on one-year outcomes in patients with acute heart failure. J Card Fail 2020; 26: 142-150.
Zishiri ET. The role of the wearable cardioverter-defibrillator in contemporary clinical practice. J Innov Card Rhythm Manag 2011; 2: 307-316.
Feldman AM, Klein H, Tchou P, Murali S, Hall WJ, Mancini D, Boehmer J, Harvey M, Heilman MS, Szymkiewicz SJ, Moss AJ. Use of a wearable defibrillator in terminating tachyarrhythmias in patients at high risk for sudden death: results of the WEARIT/BIROAD. Pacing Clin Electrophysiol 2004; 27: 4-9.
Reek S, Geller JC, Meltendorf U, Wollbrueck A, Szymkiewicz SJ, Klein HU. Clinical efficacy of a wearable defibrillator in acutely terminating episodes of ventricular fibrillation using biphasic shocks. Pacing Clin Electrophysiol 2003; 26: 2016-2022.
Epstein AE, Haines D, Bianco N, Szymkiewicz S. Wearable cardioverter-defibrillator use in patients perceived to be at high risk early post MI. J Am Coll Cardiol 2013; 62: 2000-2007.
Priori S, Blomstrom-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J, Elliott PM, Fitzsimons D, Hatala R, Hindricks G. 2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Eur Heart J 2015; 36: 2793-2867.
Adler A, Halkin A, Viskin S. Wearable cardioverter-defibrillators. Circulation 2013; 127: 854-860.
Burkhoff D, Bailey G, Gimbel JR. Characterization of cardiac acoustic biomarkers in patients with heart failure. Ann Noninvasive Electrocardiol 2020; 25: e12717.
Wang S, Lam Y, Liu M, Fang F, Wang J, Shang Q, Sun JP, Sanderson JE, Yu CM. Acoustic cardiography helps to identify heart failure and its phenotypes. Int J Cardiol 2013; 167: 681-686.
Youden WJ. Index for rating diagnostic tests. Cancer 1950; 3: 32-35.
Schjodt I, Larsen P, Johnsen SP, Stromberg A, Logstrup BB. Risk factors for readmission to hospital in adult patients with heart failure and reduced ejection fraction: a systematic review protocol. JBI Database Syst Rev Implement Rep 2017; 15: 1561-1574.
Arora S, Patel P, Lahewala S, Patel N. Etiologies, trends, and predictors of 30-day readmission in patients with heart failure. Am J Cardiol 2017; 119: 760-769.
Dharmarajan K, Lin Z, Ross JS, Horwitz LI, Barreto-Filho JA, Kim N, Bernheim SM, Suter LG, Drye EE. Diagnoses and timing of 30-day readmissions after hospitalization for heart failure, acute myocardial infarction, or pneumonia. JAMA 2013; 309: 355-363.
Conraads VM, Tavazzi L, Santini M, Oliva F, Gerritse B, Yu CM, Cowie MR. Sensitivity and positive predictive value of implantable intrathoracic impedance monitoring as a predictor of heart failure hospitalizations: the SENSE-HF trial. Eur Heart J 2011; 32: 2266-2273.
Capucci A, Santini L, Favale S, Pecora D, Petracci B, Calò L, Molon G, Cipolletta L, Bianchi V, Schirripa V, Santobuono VE, la Greca C, Campari M, Valsecchi S, Ammirati F, D'Onofrio A. Preliminary experience with the multisensor HeartLogic algorithm for heart failure monitoring: a retrospective case series report. ESC Hear Fail 2019; 6: 308-318.